United States · Investor

Easton Capital

Last cheque observed Jun 2015. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

Email

QuietVC firm

SeedSeries ASeries BHealthtechEhealthConnected-health

Cheques on record
0%of best year0cheques in 12 months, 48 on record
Since the last cheque4145days00hrs00min00sec
Median round$12MRounds led0 of 48Sole investor3 roundsExits5 from the portfolioMostly inUnited States, 97%
Pitch Easton Capital

Easton Capital highlights

  1. 01

    48 rounds on record

  2. 02

    Mostly Series B and Series A: 64% of its rounds

  3. 03

    Sole investor in 3 rounds, median $5.5M

  4. 04

    5 exits from the portfolio

What they do

Easton Capital is a leading Venture Capital Fund with a sector focus in healthcare and life sciences.From their own website
Type
VC firm (from a list, unverified)
Cheque size
Not stated
Stages
SeedSeries ASeries BGrowthPre-IPO
Sectors
HealthtechEhealthConnected-health
Based in
New York, United States
Cold pitches
Not accepted

The record

Every round we can evidence, newest first48 appearances

  1. 2015

    2 rounds

  2. Jun
    Wildflower HealthSeries B · US$5.0MWith 3 others
  3. Jan
    Kit CheckSeries B · US$12MWith 5 others
  4. 2014

    7 rounds

  5. Oct
    MediklyVenture · USUndisclosedWith 2 others
  6. Aug
    Claret MedicalSeries B · US$18MWith 2 others
  7. Jun
    ElectroCoreSeries A · US$50MWith 2 others
  8. May
    MedCPUSeries B · US$9.3MWith 2 others
  9. Mar
    WellTrackONE, CorporationSeries A · US$1.5MWith 2 others
  10. Feb
    Respiratory MotionSeries B · US$5.8MSole investor
  11. Jan
    TigerTextSeries B · US$21MWith 6 others
  12. 2013

    2 rounds

  13. Jun
    Kit CheckSeries A · US · techcrunch.com$10MWith 4 others
  14. Feb
    MediklySeries A · US · pehub.com$1.2MSole investor
  15. 2012

    6 rounds

  16. Dec
    Within3Growth · US · reuters.com$20MWith 2 others
  17. Nov
    Resolve TherapeuticsSeries B · US · finsmes.com$5.8MWith 2 others
  18. Aug
    Achronix SemiconductorVenture · US · gslb.cleanrooms.com$9.8MWith 2 others
  19. Mar
    PromediorSeries D · US · fiercebiotech.com$22MWith 5 others
  20. Feb
    TigerTextSeries B · US · finsmes.com$8.2MWith 1 other
  21. Feb
    TigerTextSeries A · US$8.2MWith 1 other
  22. 2011

    2 rounds

  23. May
    Resolve TherapeuticsSeries A · US · xconomy.com$2.0MWith 1 other
  24. Apr
    bluebird bioVenture · US · live-pr.com$30MWith 4 others
  25. 2010

    2 rounds

  26. Jun
    Format DynamicsSeries B · US · businesswire.com$5.5MSole investor
  27. Mar
    bluebird bioSeries B · US · fiercebiotech.com$35MWith 4 others
  28. 2009

    2 rounds

  29. Dec
    Coapt SystemsDebt · US · deals.venturebeat.com$3.7MWith 7 others
  30. Oct
    CardioMEMSSeries F · US · onbiovc.com$22MWith 9 others
  31. 2008

    4 rounds

  32. Nov
    PlaySpanSeries B · US · techcrunch.com$17MWith 3 others
  33. Oct
    Achronix SemiconductorSeries B · US · achronix.com$52MWith 4 others
  34. Jul
    PlaySpanVenture · US · venturedeal.com$5.0MWith 3 others
  35. Jan
    Cardiovascular SystemsSeries B · US$11MWith 1 other
  36. 2007

    11 rounds

  37. Nov
    Wirecom TechnologiesSeries B · FR$5.8MWith 4 others
  38. Sept
    GoCrossCampusSeed · US · nytimes.com$375KWith 1 other
  39. Sept
    PlaySpanSeries A · US · techcrunch.com$6.5MWith 3 others
  40. Jul
    IGA WorldwideSeries B · US · igaworldwide.com$25MWith 5 others
  41. Jun
    GentisSeries A · US · venturebeat.com$10MWith 3 others
  42. May
    Biolex TherapeuticsSeries C · US · biolex.com$30MWith 8 others
  43. Apr
    LaminaSeries D$7.0MWith 4 others
  44. Mar
    Coapt SystemsSeries E · US · deals.venturebeat.com$23MWith 6 others
  45. Feb
    Sanarus MedicalSeries E · US · deals.venturebeat.com$15MWith 6 others
  46. Feb
    Trellis BioscienceSeries B · US · deals.venturebeat.com$10MWith 4 others
  47. Jan
    Achronix SemiconductorSeries A · US · prnewswire.com$25MWith 3 others
  48. 2006

    3 rounds

  49. Nov
    CardioMEMSSeries D · US$23MWith 4 others
  50. May
    PromediorSeries A · US$14MWith 4 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 8 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What they claim to have backed

From their own portfolio page (on their website)

1 of 6 we have independently watched raise

PicturePicturePicturePicturePicturePicture

Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.

Exits from the portfolio

Companies it backed that were later bought or listed5 in all

bluebird bioListed$101MJun 2013
PlaySpanBought by Visa$190MFeb 2011
XoftBought by iCAD$73MDec 2010
Coapt SystemsBought by MicroAireUndisclosedAug 2010
Cardiovascular SystemsListed$85MFeb 2009

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Easton Capital. A count of rooms they were both in, not a relationship either has claimed.

New Science VentureVC firm8rounds togetherMorgenthaler VenturesVC firm6rounds togetherBoston Millennia PartnersPrivate equity5rounds togetherFoundation Medical PartnersPrivate equity4rounds togetherTVM CapitalPrivate equity4rounds togetherAlta PartnersVC firm3rounds togetherCanaanVC firm3rounds togetherForbion Capital PartnersPrivate equity3rounds togetherGlobal Life Science VenturesGrowth equity3rounds togetherMenlo VenturesVC firm3rounds togetherNew Leaf Venture PartnersVC firm3rounds togetherPolaris PartnersVC firm3rounds together

Quick answers about Easton Capital

What does Easton Capital invest in?

Easton Capital invests most often at Series B and Series A (64% of the rounds on record), in sectors such as Healthtech, Ehealth and Connected-health.

How active is Easton Capital?

48 investments on record, 0 of them in the last 12 months. The most recent was in Jun 2015.

How big are Easton Capital's cheques?

The median round it joins is $12M.

Does Easton Capital lead rounds?

Rarely, if at all: none of its 48 investments on record names it as the lead.

Where does Easton Capital invest?

Most of the companies it backs are in the United States (97%).

Is Easton Capital investing now?

No investments in the last 12 months; the latest was in Jun 2015.

Who does Easton Capital invest alongside?

Most often New Science Venture (8 rounds together), Morgenthaler Ventures (6 rounds together) and Boston Millennia Partners (5 rounds together).

What kind of investor is Easton Capital?

Easton Capital is a VC firm based in New York, United States.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it